https://rjrindex.com/articles/time-to-quality-of-life-qol-improvement-or-deterioration-in-patients-pts-with-primary-advanced-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-immunotherapy-associated-cardiotoxicities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-an-epigenomic-based-classifier-to-identify-cancer-signal-of-origin-on-liquid-biopsy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-spectrum-of-cutaneous-carcinoma-a-single-center-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elranatamab-in-combination-with-daratumumab-and-lenalidomide-edr-in-patients-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-abbv-400-temab-a-monotherapy-vs-trifluridinetipiracil-plus-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-clinical-outcomes-for-solid-tumours-a-pooled-ipd-meta-analysis-of-contempo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-adg126-an-anti-ctla-4-masking-antibody-in-combination-with-pembrolizumab-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-based-minimal-residual-disease-mrd-measured-by-guardant-reveal-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-as-a-predictor-of-treatment-response-in-metastatic-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hospital-systems-on-surgical-outcomes-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-validation-study-of-ai-powered-pd-l1-analyzer-compared-to-pathologists-assessment-of-pd-l1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duration-of-response-dor-following-treatment-with-ugn-102-in-patients-with-recurrent-low-grade-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-rc48-tislelizumab-and-s-1-as-first-line-therapy-for-her2-overexpressing-advanc-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-smartwatch-based-electrocardiogram-ecg-abnormality-detection-among-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-from-ichoice-02-a-phase-2-trial-of-induction-chemoimmunotherapy-followed-by-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-observational-study-on-health-resource-utilization-and-patterns-of-care-for-skeletal-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-acr-368-and-low-dose-gemcitabine-combination-therapy-in-patients-with-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-surgical-delay-beyond-8-weeks-on-tumor-progression-and-lymph-node-involvement-in-early-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physical-rehabilitation-program-for-cardiorespiratory-health-and-quality-of-life-among-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-predictors-of-older-cancer-patients-in-bangladesh-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-racial-and-regional-disparities-in-breast-cancer-mortality-among-the-female-population-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-quality-of-life-superiority-in-modern-phase-iii-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-tumor-immune-microenvironment-changes-with-neoadjuvant-chemotherapy-and-cemipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-study-of-multicentric-gliomas-stratified-by-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analyses-from-a-global-meta-analysis-in-metastatic-uveal-melanoma-mum-to-determine-progres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cellular-proliferation-and-tumor-suppression-pathways-as-potential-targets-in-clinically-aggressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irinotecan-liposome-in-chinese-patients-with-advanced-pancreatic-cancer-a-prospective-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/career-transitions-and-practice-patterns-among-international-medical-graduates-in-oncology-workforce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-and-other-causes-of-physician-attrition-a-qualitative-study-of-physicians-leaving-direct-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-reality-for-pain-and-anxiety-management-during-bone-marrow-biopsy-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-of-25-patients-treated-with-echoendoscopically-implanted-sup32sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tqb2868-combined-with-anlotinib-and-nab-paclitaxel-plus-gemcitabine-as-first-line-treatment-for-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-readmission-rates-length-of-stay-and-mortality-among-bone-marrow-transplant-and-car-t-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-stereotactic-body-radiotherapy-vs-conventional-radiotherapy-for-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-in-stage-iii-alk-nsclc-patients-in-china-a-multicenter-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-determinants-of-survival-of-hepatoid-adenocarcinoma-of-the-lungs-analysis-of-a-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-atezolizumab-combined-with-cisplatin-and-vinorelbine-as-adjuvant-therapy-for-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-liquid-biopsy-with-qpcr-validation-a-machine-learning-based-model-for-lung-cancer-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-egfr-mutated-non-small-cell-lung-cancer-treated-with-surgery-exerpos-02-gfpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-epidemiology-and-impact-on-clinical-outcomes-in-non-hodgkin-lymphoma-patients-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-in-trimodality-therapy-for-bladder-cancer-overcoming-chemoradiotherapy-resistance-via 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-htmc0435-combination-with-temozolomide-in-relapsed-extensive-stage-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-on-small-cell-lung-cancer-survival-a-focus-on-treatment-setting-race-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-bxq-350-a-novel-sphingolipid-metabolism 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-decision-support-system-based-on-artificial-intelligence-and-the-patients-subjective-inten 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-to-evaluate-the-safety-and-efficacy-of-switchable-car-t-cell-therapy-with-fy001-and-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-clinical-validation-of-a-cell-free-dna-methylation-sequencing-test-for-multi-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-among-patients-with-pancreatic-cancer-pc-a-pancreatic-cancer-action-netw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-subtypes-of-follicular-lymphoma-revealed-by-tumor-and-immune-cell-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-bladder-cancer-mortality-the-influence-of-tobacco-use-and-sociodemographic-factors-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preventative-intervention-uptake-among-women-with-breast-cancer-and-pathogenic-germline-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-hospital-based-cancer-registry-in-planning-the-cancer-control-program-in-semiurban-setting-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-profile-of-fruquintinib-fruq-versus-regorafenib-rego-in-refractory-metastatic-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-outcomes-of-pseudoadjuvant-chemotherapy-for-resectable-metastatic-colon-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-the-number-of-circulating-epithelial-tumor-cells-cetcsctcs-and-circulating-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-lung-cancer-development-using-chest-x-ray-with-microrna-samples-in-health-screening-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-patients-with-metastatic-colorectal-cancer-mcrc-treated-with-trifl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-neutrophil-to-lymphocyte-ratio-in-small-cell-lung-cancer-in-the-era-of-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dalpiciclib-plus-toremifene-in-advanced-hr-positive-her2-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-risk-of-second-primary-lung-cancer-among-initial-lung-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-of-pyrotinib-in-her2-positive-metastatic-breast-cancer-a-multicenter-real-world-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-review-of-early-onset-colorectal-cancer-10-year-retrospective-clinical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pressure-related-injury-on-hospitalized-patients-with-colorectal-cancer-a-united-states-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-pan-cancer-universal-germline-testing-in-an-ethnically-diverse-and-rural-community 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-single-arm-prospective-clinical-study-initiated-by-a-researcher-on-the-efficacy-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-predictors-of-lymphatic-leak-after-nephrectomy-using-american-college-of-surgeons-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-risk-scoring-system-for-the-prediction-of-early-infection-after-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-mk2-inhibitor-in-combination-with-mfolfirinox-for-untreated-metastatic-pancreatic-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-perioperative-intraperitoneal-paclitaxel-in-patients-with-gastric-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-and-lifestyle-changes-during-and-after-therapy-in-women-with-endometrial-cancer-a-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-sacituzumab-govitecan-for-advanced-esophageal-squamous-cell-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-outcomes-of-t-cell-prolymphocytic-leukemia-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-inequities-in-retinoblastoma-treatment-a-seer-based-analysis-of-race-ethnicity-geograph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-in-clinical-trials-evaluating-lifestyle-interventions-targeting-energy-balance-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-imaging-of-the-immunotherapy-and-radioimmunotherapy-response-by-immunopet-via-a-new-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-regional-and-national-burden-of-soft-tissue-sarcomas-and-other-extraosseous-sarcomas-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1a1b-trial-in-relapsedrefractory-t-cell-non-hodgkin-lymphoma-to-determine-the-safety-profi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-the-apricitycare-program-for-early-detection-and-management-of-treatment-related-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-sup68sup-ga-fapi-petct-and-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-third-line-and-later-3l-therapies-post-poly-adp-ribose-polymerase-inhibitor-parpi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-the-performance-of-ovarian-cancer-score-for-diagnosing-ovarian-cancer-in-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-the-efficacy-and-safety-of-adebrelimab-in-combination-with-lenvatinib-as-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-powered-evaluation-of-protein-drug-targetability-through-subcellular-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-camrelizumab-plus-apatinib-and-gemcitabine-oxaliplatin-in-patients-with-borderline-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-clinical-study-to-evaluate-the-safety-tolerability-pharmacokinetic-profile-and-prelimin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-situational-analysis-of-pediatric-cancer-diagnostic-and-research-capacity-at-two-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-patient-reported-outcomes-pros-in-men-with-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-incidence-and-mortality-among-aya-patients-with-lung-adenocarcinoma-and-squamo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-determinants-of-survival-of-hepatoid-adenocarcinoma-of-the-stomach-analysis-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-immune-and-metabolic-markers-with-clinical-outcomes-in-the-enzamet-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wildfire-smoke-risk-mitigation-behaviors-and-cancer-risk-a-community-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-treatment-on-overall-survival-for-patients-with-oropharyngeal-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-in-breast-cancer-patients-receiving-adjuvant-chemotherapy-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychosocial-digital-application-for-caregivers-of-patients-undergoing-hematopoietic-stem-cell-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-serum-sodium-as-a-prognostic-factor-for-patients-with-advanced-esophageal-cancer-receiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemoradiation-followed-by-surgery-on-outcomes-compared-to-definitive-chemoradiation-in-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-the-benefits-and-resistance-mechanisms-of-immunotherapy-based-on-pd-l1-expression-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-bispecific-antibodies-bsabs-administration-in-community-oncology-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stop-cancelling-surgery-for-esophageal-cancer-an-analysis-of-treatment-related-mortality-in-60000 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-sentinel-node-biopsy-in-early-invasive-breast-cancer-does-age-matter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-assessing-the-efficacy-and-safety-of-mcapox-plus-cetuximab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychologic-distress-amongst-adolescent-and-young-adult-cancer-survivors-and-parents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerated-aging-among-long-term-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-smarca4-deficiency-and-stk11-co-mutations-on-non-small-cell-lung-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunoembolization-in-liver-predominant-metastatic-uveal-melanoma-a-single-center-retrospective-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-associations-between-chronic-health-condition-burden-and-financial-hardship-among-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depth-of-response-and-progression-free-survival-in-patients-with-advanced-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-adverse-events-associated-with-kimmtrak-in-metastatic-uveal-melanoma-using-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-alterations-identification-and-potential-shared-neoantigens-for-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-cisplatin-regimens-for-locoregionally-advanced-head-and-neck-squamous-cell-carcinoma-a-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revisiting-the-relevance-of-sidedness-in-colonic-tumor-molecular-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-survival-of-first-line-atezolizumab-nivolumab-and-pembrolizumab-in-older-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pucotenlimab-combined-with-standard-chemotherapy-regimens-in-the-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-chemotherapy-completion-and-adverse-events-among-patients-with-colon-cancer-calg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-in-pakistan-frequency-and-association-with-stage-and-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-laryngeal-carcinoma-related-mortality-among-adults-in-the-united-states-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-soliq-molecular-profiling-using-whole-exome-sequencing-in-advanced-hnscc-at-baseline-les 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-dynamic-circulating-tumor-dna-ctdna-based-mrd-for-predicting-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-yoga-vyocas-intervention-for-psychological-distress-a-decentralized-digital-randomized-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-shared-genomic-drivers-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-sectional-study-on-the-impact-of-receiving-potentially-sensitive-test-results-online-on-the-em 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-gender-demographics-and-equity-among-hematologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-clinical-outcomes-of-sweet-syndrome-in-hospitalized-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-impact-of-delays-to-radiotherapy-on-prostate-cancer-mortality-in-localized-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-physiologic-and-behavioral-monitoring-to-predict-early-treatment-response-in-metastatic-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropsychiatric-disorders-among-patients-with-breast-cancer-during-the-covid-19-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-flexible-and-extended-dosing-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mvp-can-model-accelerating-cancer-diagnosis-for-underserved-inpatients-to-bridge-health-gaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facs-based-whole-genome-crispri-screen-to-uncover-steap1-regulators-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/door-to-door-oral-cancer-screening-for-22278-individuals-february-2020-april-2024-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-benefits-of-using-a-different-donor-for-transplantation-consolidation-after-donor-derived 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-attitudes-and-practices-of-breast-cancer-screening-among-women-in-rural-communities-in-fc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-predictive-biomarkers-of-anti-egfr-resistance-in-egfr-mutated-non-small-cell-lung-cancer-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abiraterone-with-discontinuation-of-gonadotropin-releasing-hormone-gnrh-analogues-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imaging-and-biomarker-factors-for-predicting-durable-responses-to-177lu-psma-therapy-in-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-predictive-tool-for-identifying-druggable-mutations-in-lung-cancer-using-nationwide-compreh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-based-spatial-assessment-of-tumor-infiltrating-lymphocytes-til-and-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/innovative-data-visualization-tool-for-tracking-system-failures-in-colorectal-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-machine-learning-approach-to-breast-cancer-screening-using-non-invasive-mrna-collection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-preferences-for-supplemental-methods-of-communication-of-new-drug-approvals-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tackling-the-high-economic-impact-of-recurrence-in-resected-medicare-patients-with-early-stage-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-gene-set-discovery-via-scrna-seq-for-optimal-deep-learning-based-downstream-tasks-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-co-occurring-tp53-and-intracellular-proliferation-pathway-mutations-on-disease-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-use-of-g-csf-in-patients-with-small-cell-lung-cancer-sclc-secondary-data-analysis-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linking-gene-expression-to-tumor-microenvironment-using-hampe-features-in-stomach-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-g-csf-primary-prophylaxis-on-prevention-of-severe-neutropenia-in-folfirinox-therapy-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targetable-mutations-in-cutaneous-skin-cancers-a-comparative-study-across-melanoma-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-quality-of-life-improvements-in-radiation-cystitis-and-head-and-neck-cancer-patients-foll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-prediction-of-cancer-associated-thrombosis-to-guide-prophylactic-anticoagulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unresectable-advanced-cutaneous-squamous-cell-carcinoma-patient-characteristics-and-outcomes-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurocognitive-outcomes-following-306-gy-whole-ventricular-radiotherapy-with-54-gy-total-dose-focal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-versus-concurrent-strategy-of-immunotherapy-and-radiotherapy-in-advanced-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-non-bcma-car-t-cell-therapy-for-multiple-myeloma-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-powered-hampe-whole-slide-image-analysis-of-endothelial-cells-to-characterize-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-niraparib-induced-changes-in-glucose-levels-during-three-month-therapy-in-normoglycemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-neoadjuvant-chemotherapy-andor-osimertinib-in-patients-with-iegfr-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidermal-growth-factor-receptor-egfr-inhibitor-induced-dermal-toxicity-treated-with-topical-appli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-trial-of-talazoparib-in-combination-with-belinostat-in-select-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-targeted-glioblastoma-therapies-by-iex-vivoi-drug-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-12a-study-of-pbp1510-anti-pauf-mab-in-advancedmetastatic-pancreatic-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-pathology-based-multimodal-artificial-intelligence-biomarker-for-predicting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-brain-metastasis-in-adolescent-and-young-adult-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-the-randomized-phase-2-study-1801-part-3b-of-elraglusib-in-combination-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-treatment-patterns-and-survival-outcomes-in-biliary-tract-cancers-a-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-and-safety-of-hyperthermic-intraperitoneal-chemotherapy-hipec-as-an-adjunc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analyses-of-homologous-recombination-repair-alterations-hrrm-by-gene-subgroup-and-pote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-and-effective-strategies-to-improve-biomarker-testing-rates-in-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-impact-of-non-exonuclease-ipolei-and-ipold1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/network-pharmacology-analysis-of-phytochemicals-in-targeting-cancer-a-systems-biology-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cryoablation-combined-with-camrelizumab-and-apatinib-in-advanced-hepatocellular-carcinoma-a-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-glycemia-in-non-diabetic-patients-with-metastatic-melanoma-undergoing-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-bg-c9074-a-b7-h4-targeting-adc-in-patients-with-advanced-solid-tumors-prel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-progression-free-survival-and-overall-survival-in-relapsedrefractory-diffuse-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-and-duration-of-response-for-transfusion-independence-ti-in-erythropoiesis-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-homologous-recombination-deficiency-and-brca-status-in-ovarian-cancer-analytical-perf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-drivers-of-mhc-repression-and-therapeutic-strategies-to-counter-immune-evasion-in-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-patients-with-brain-metastases-secondary-to-melanoma-treated-with-nivolumabr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-dietary-patterns-on-inflammation-and-colon-cancer-risk-a-retrospective-study-of-796-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-circulating-tumor-dna-ctdna-dynamics-with-clinical-response-in-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tarlatamab-in-patients-with-relapsed-extensive-stage-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-incidence-and-survival-of-uveal-melanoma-a-seer-based-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-ctc-and-ev-based-detection-of-psma-protein-and-efficacy-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-salmonella-il2-in-combination-with-folfirinox-on-overall-and-progression-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-first-in-human-phase-12-study-of-tsn1611-a-highly-selective-kras-g12d-inhibitor-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-insights-into-the-impact-of-an-ambient-ai-scribe-solution-on-clinical-documentation-to-reduce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-parp-inhibitor-regimen-in-ovarian-cancer-ipiroc-a-proof-of-concept-exploratory-pragm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-baseline-and-post-progression-tumors-in-immotion010-a-randomized-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-treatment-decisions-with-liquid-biopsy-ngs-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-development-of-the-cost-of-cancer-in-31-european-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1a-dose-escalation-study-of-rs-0139-a-novel-tumor-targeted-nanomedicine-for-advanced-solid-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-blood-based-multi-cancer-detection-in-circulating-tumor-dna-ctdna-5-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-clinical-trial-evaluating-perioperative-therapy-neoadjuvant-chemotherapy-ver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/origami-3-a-randomized-phase-3-study-of-amivantamab-plus-folfiri-vs-cetuximab-or-bevacizumab-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-dose-ptcy-in-patients-with-acute-myeloid-leukemia-receiving-matched-unrelated-donor-allogene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-of-observerships-abroad-lessons-from-ua-med-supporting-ukrainian-cancer-care-during-the-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-time-to-treatment-failure-ttf-as-a-surrogate-endpoint-for-overall-survival-os-to-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-etentamig-a-b-cell-maturation-antigen-bcma-bispecific-antibody-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-patients-with-multiple-myeloma-and-renal-failure-in-the-united-states-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intersectional-disparities-in-mortality-of-laryngeal-cancer-a-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subsequent-treatments-and-outcomes-in-bacillus-calmette-guerin-unresponsive-patients-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-phase-iii-clinical-trial-of-novel-biosimilar-of-pembrolizumab-rph-075 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-on-incidence-and-survival-in-kaposi-sarcoma-during-the-post-retroviral-era-a-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-transplant-supportive-and-palliative-care-andor-comorbidity-management-for-older-medically-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-trends-and-disparities-in-end-of-life-care-for-acute-myeloid-leukemia-a-2019-2021-nis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-prognostic-risk-score-for-hepatocellular-carcinoma-recurrence-post-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pancreas-tissue-bank-pcrftb-global-facilitation-of-pancreatic-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-outcomes-of-gastrointestinal-malignancies-treated-with-early-phase-studies-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/board-certification-and-billing-practices-of-international-medical-graduate-hematologists-and-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-place-of-death-in-patients-with-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-tyrosine-kinase-inhibitors-and-other-targeted-therapies-in-imatinib-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choosing-oncology-a-cross-sectional-study-of-caribbean-medical-students-fourth-year-elective-rotat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-prospective-validation-of-a-novel-cfdna-based-diagnostic-model-for-the-early-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-of-ultrafine-gold-nanoparticles-aunps-as-radio-contrast-agent-for-early-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/higher-school-of-oncology-a-decade-of-advancing-oncology-training-in-resource-limited-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-debulking-versus-non-surgical-management-for-the-control-of-carcinoid-syndrome-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-nivolumab-and-ipilimumab-combined-with-gemcitabine-nab-paclitaxel-and-adaptive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-pancreatic-cancer-molecular-characterization-therapeutic-implications-and-survival-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-recurrence-detection-in-stage-iii-colorectal-cancer-patients-through-molecular-residual-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-molecularly-targeted-trials-of-tyrosine-kinase-inhibitors-tki-for-the-periop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-patterns-of-recurrence-in-a-cohort-treated-with-pacific-protocol-a-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-zavatar-test-guided-chemotherapy-vs-standard-of-care-in-relapsed-ovarian-cancer-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-molecular-search-engine-paired-with-rna-sequencing-analysis-to-develop-potent-and-selective-vegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-biomarker-rct-in-women-at-high-risk-for-breast-cancer-low-dose-tamoxifen-and-lifestyle-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-multimodal-multidisciplinary-care-on-clinical-outcomes-in-patients-with-breast-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammography-results-in-male-ibrcai-carriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positron-emission-tomography-utility-for-progression-free-survival-prediction-in-her2-positive-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-beyond-progression-and-rechallenge-with-pyrotinib-in-her2-positive-metastatic-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-trend-of-breast-cancer-attributable-to-high-red-meat-consumption-in-the-united-states-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-precise-car-t-bridging-therapy-for-diffuse-large-b-cell-lymphoma-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-br007-a-phase-iii-trial-evaluating-de-escalation-of-breast-radiation-debra-following-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-hdac-iiib-selective-inhibitor-purinostat-mesylate-in-relapsed-and-refractory-diffuse-large-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-allostatic-load-and-breast-radiomic-features-among-diverse-women-undergoing-scre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-trimodal-therapy-on-survival-outcomes-in-non-urothelial-muscle-invasive-bladder-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-stimulated-raman-histology-based-cellularity-for-random-forest-prediction-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paired-dnarna-genetic-testing-to-uncover-cryptic-pathogenic-variants-pv-associated-with-pten-hama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-disease-in-breast-cancer-analysis-of-risk-factors-and-outcomes-from-the-2022-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-neoadjuvant-chemotherapy-nac-anti-her2-antibodies-mabs-on-gut-microbiome-composi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-from-targeted-axillary-lymph-node-dissection-after-neoadjuvant-chemotherapy-for-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-asian-americans-with-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tazemetostat-in-patients-with-refractoryrelapsed-follicular-lymphoma-or-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-metastatic-renal-cell-carcinoma-database-consortium-imdc-classification-and-regressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-raceethnicity-on-outcomes-in-patients-with-follicular-lymphoma-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-clinical-characteristics-with-the-use-of-proteomic-testing-for-lung-nodule-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-cell-subsets-and-cytokine-profiles-with-immune-related-hyperinflammatory-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/znf74-as-a-novel-therapeutic-target-in-melanoma-unveiling-mechanisms-and-developing-precision-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-peripheral-cancer-associated-tcr-signals-for-the-early-detection-of-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-predictive-model-for-survival-outcome-of-patients-with-early-stage-medullary-breast-carcinoma-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-non-small-cell-lung-cancer-real-world-analysis-of-immunotherapy-era-vs-pre-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-homologous-recombination-deficiency-hrd-in-metastatic-colorectal-cancer-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-binimetinib-plus-imatinib-in-patients-with-unresectable-kit-mutant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-for-head-and-neck-squamous-cell-carcinoma-treated-with-versus-without-neoadjuvant-systemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-aspiration-pneumonia-related-to-postoperative-chemoradiotherapy-for-high-risk-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elcin-elacestrant-in-women-and-men-with-cdk46-inhibitor-cdk46i-naive-estrogen-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-demographic-and-socioeconomic-patterns-in-hidradenocarcinoma-a-retrospective-national-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-clinical-panthological-factors-of-acral-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-oral-nepa-versus-fosaprepitant-combined-with-palonosetron-for-preventing-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-fixed-dose-regimens-of-serplulimab-an-anti-pd-1-antibody-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-outcomes-of-colorectal-cancer-in-a-resource-restricted-countr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-expansion-data-from-iintune-1-a-phase-12-study-of-the-sting-agonist-dazostinag-plus-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-bys10-in-patients-pts-with-locally-advanced-or-metastatic-ret-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-real-world-validation-of-a-multi-modal-machine-learning-model-to-predict-response-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-demographics-and-patterns-of-colon-cancer-in-the-united-states-a-comprehensive-seer-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-outcomes-in-immune-checkpoint-inhibitor-colitis-a-study-comparing-initial-endoscopic-and-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-nk-1-receptor-antagonist-based-therapy-for-prevention-and-treatment-of-chemot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-insights-of-trastuzumab-deruxtecan-efficacy-in-advanced-breast-cancer-abc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-cervical-cancer-in-uzbekistan-trends-in-incidence-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-combined-with-tkis-for-recurrent-or-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-circulating-tumor-dna-and-tissue-genomic-profiling-in-ovarian-cancer-influencing-fac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-of-high-fidelity-simulation-versus-mentoring-training-for-residents-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-2-trial-exploring-the-use-of-pamiparib-combined-with-surufatinib-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gynecologic-oncology-referral-rates-of-adnexal-masses-suspicious-for-ovarian-cancer-in-an-academic-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quadrant-of-co-occurrence-of-circulating-tumor-dna-and-pd-l1-expression-on-circulating-tumor-cells-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinguishing-tumor-vs-clonal-hematopoiesis-ch-derived-itp53i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-racial-demographic-reporting-in-clinical-studies-supporting-nccn-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-time-to-completion-of-multi-target-stool-dna-testing-a-retrospective-study-across-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-and-patient-engagement-with-a-novel-digital-platform-for-cancer-care-navigation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-treatment-initiation-on-overall-survival-for-patients-with-osteosarcoma-a-seer-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-for-social-needs-and-providing-enhanced-support-preliminary-findings-from-a-multi-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-abuse-among-adults-with-esophageal-cancer-and-impact-on-outcomes-of-esophagectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-claudin-182-cld182-in-gastric-cancers-and-clinical-correlation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-frailty-and-clinical-outcomes-in-older-adults-with-early-breast-cancer-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-pharmacovigilance-study-of-myelotoxicity-with-parp-inhibitors-in-breast-and-ovarian-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-sarcopenia-diagnosis-defined-by-low-muscle-mass-measured-by-bioelectrical-impedance-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-of-postoperative-functional-status-in-gastrointestinal-and-hepatobiliary-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-socioeconomic-and-geographic-disparities-on-early-mortality-and-treatment-related-complica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-data-to-dollars-evaluating-the-predictive-power-of-enhancing-oncology-model-risk-adjusters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variations-in-psma-pet-utilization-psa-testing-and-urologist-involvement-in-advanced-castrate-resi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancement-of-30-day-acute-care-event-prediction-model-following-outpatient-chemotherapy-using-vita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-for-evidence-based-treatment-recommendation-in-oncology-a-blinded-evaluation-of-large-language-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-specific-antigen-psa-screening-from-fingerstick-blood-initial-validation-of-a-point-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-circulating-tumor-cells-and-pten-loss-in-localized-prostate-cancer-before-and-after-rad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-older-matched-sibling-donors-compared-to-younger-matched-unrelated-donors-in-allogeneic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-mortality-trends-in-the-us-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-patterns-of-breast-cancer-recurrence-in-young-women-a-us-population-based-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparate-recovery-of-cancer-screenings-by-demographic-in-traditional-medicare-post-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-biomarker-testing-and-targeted-therapy-integration-in-early-stage-nsclc-a-quality-improv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-collaborative-care-in-oncology-improving-quality-of-life-and-mental-health-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-beyond-the-unknown-primary-investigating-histopathology-after-diagnostic-transoral-robot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-of-the-tumor-microenvironment-in-egfr-and-kras-mutant-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-prognostic-score-for-stage-iv-nsclc-using-advance-machine-learning-algorithms-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-cbdca-pem-pembrolizumab-in-elderly-75-yrs-patients-with-advanced-non-sq-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-high-risk-group-according-to-oncotype-dx-recurrence-score-using-dynamic-contrast-enhanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-the-collection-of-patient-reported-outcomes-key-factors-influencing-completion-and-drop-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-and-days-at-home-in-the-year-after-surgery-for-ovarian-cancer-a-patient-centered-outcome-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-induced-vasomotor-symptoms-in-patients-with-hr-breast-cancer-receiving-adjuvant-endocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-outcomes-of-cancer-patients-on-medicaid-versus-private-insurance-admitted-to-the-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hot-flashes-and-night-sweats-in-women-with-breast-cancer-prevalence-and-severity-of-symptoms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-venous-thromboembolism-vte-events-in-patients-with-egfr-mutant-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-lung02-datopotamab-deruxtecan-dato-dxd-plus-pembrolizumab-pembro-with-or-without-platin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imaging-with-sup89sup-zrzr-dfo-sc1656-anti-dll3-antibody-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-value-of-comprehensive-genomic-profiling-in-patients-with-advanced-solid-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-potent-and-selective-fourth-generation-inhibitors-targeting-egfr-for-nsclc-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-observational-study-to-evaluate-efficacy-and-safety-of-immunotherapy-io-in-elderly-el 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chylopericardium-and-chylous-effusions-during-treatment-with-selective-ret-inhibitors-selpercatinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-population-level-costs-and-cost-savings-associated-with-long-term-follow-up-ltfu-screening-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-safety-and-efficacy-of-gt201-a-first-in-class-autologous-tumor-infiltrating-lymphocyt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-in-combination-with-epirubicin-followed-by-maintenance-anlotinib-versus-placebo-plus-epiru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-contribution-of-metabolic-risk-factors-to-uterine-cancer-related-deaths-and-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerald-y90-a-phase-2-study-to-evaluate-transarterial-radioembolization-tare-followed-by-durvalum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-followed-by-sintilimab-and-capox-as-total-neoadjuvant-treatment-in-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-single-arm-pragmatic-trial-in-progress-of-in-home-versus-in-clinic-subcutaneous-nivolumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/human-vs-ai-a-comparative-effectiveness-study-of-large-language-models-for-automated-biomarker-ext 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-and-cancer-care-delivery-an-updated-real-world-analysis-of-the-impact-of-telehealth-on-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prognostic-classification-system-for-extent-of-resection-in-idh-mutant-grade-2-glioma-a-report-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-state-of-the-oncologist-workforce-in-america-in-areas-prone-to-natural-disasters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ihelicobacter-pylorii-infection-on-molecular-alterations-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-plus-bevacizumab-in-irinotecan-refractory-metastatic-colorectal-cancer-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-investigation-for-the-tumor-immune-microenvironment-and-spatial-heterogeneity-in-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-either-ivosidenib-monotherapy-or-azacitidine-monotherapy-in-patients-with-idh1-muta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ca209-8ty-trial-a-randomized-phase-2-trial-of-nivolumab-and-ipilimumab-with-or-without-stereotactic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-an-enhanced-telehealth-program-for-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depression-in-patients-with-advanced-prostate-cancer-in-swog-advanced-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chitinase-3-like-1-ichi3l1i-a-potential-prognostic-biomarker-for-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-clinical-predictors-of-cranial-nerve-palsies-cnps-post-ciltacabtagene-autoleucel-ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-stereotactic-radiotherapy-and-enfortumab-vedotin-a-phase-iii-study-for-localized-cisp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-with-platinum-based-chemotherapy-after-enfortumab-vedotin-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-of-neoantigen-specific-immune-responses-by-vb10neo-in-combination-with-atezolizumab-in-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-irinotecan-liposome-combined-with-5-fulv-bevacizumab-as-first-line-therapy-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modernizing-clinical-trial-accessibility-integrating-the-ai-powered-lookuptrials-app-into-the-ctn-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-eik1003-a-selective-parp1-inhibitor-as-monotherapy-in-participants-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-tqb2103-a-claudin182-cldn182-targeted-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-phase-1-study-of-lb1908-an-autologous-claudin-182-targeted-chimeric-antig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teclistamab-in-relapsedrefractory-systemic-al-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-serplulimab-combined-with-gemcitabine-plus-nab-paclitaxel-gnp-and-sbrt-for-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-bruton-tyrosine-kinase-inhibitor-btki-use-and-clinical-outcomes-among-patients-with-chr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-factors-affecting-aesthetic-outcomes-and-safety-in-breast-conserving-surgery-a-multicen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-anti-pd-1-monoclonal-antibody-and-folfoxiri-combined-with-long-course-radiotherapy-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propan-bayesian-dose-finding-of-propranolol-combined-with-metronomic-fixed-dose-cyclophosphamide-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bms-986504-in-patients-pts-with-advanced-solid-tumors-with-homozygous-imtap-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-as-monotherapy-or-in-sequential-combination-with-lenvatinib-for-neoadjuvant-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-hypertension-in-patients-newly-diagnosed-with-chronic-lymphocytic-leukemiasmall-lymphocytic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-diversity-in-oncology-trials-key-strategies-from-the-acori-community-oncology-inclusive-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-type-of-brca12-pathogeniclikely-pathogenic-variants-and-outcome-in-young-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ropeginterferon-alfa-2b-versus-anagrelide-for-the-treatment-of-essential-thrombocythemia-topline-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-of-lung-cancer-in-north-america-versus-globally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-less-frequent-dosing-with-elranatamab-elra-in-patients-with-relapsed-or-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-dietary-factors-on-esophageal-cancer-over-three-decades-a-global-epidemiological-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sox30-mediated-activation-of-cxcl2-as-promotor-of-pmn-mdsc-recruitment-and-immunosuppressive-microen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palbociclib-plus-endocrine-therapy-or-gnrh-analogs-versus-capecitabine-or-placebo-for-hrher2-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-plus-pd-1-inhibitor-tislelizumab-for-high-risk-and-mrf-low-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-morbidity-outcomes-in-patients-with-inflammatory-bowel-disease-with-colon-cancer-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-for-metastatic-her2-and-her2-low-breast-cancer-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-colorectal-cancer-and-iron-deficiency-anemia-related-mortality-in-the-united-states-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-expression-of-human-endogenous-retrovirus-env-gene-product-as-a-hallmark-of-sidedness-in-operabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operetta-a-phase-ii-study-evaluating-neoadjuvant-and-adjuvant-olaparib-plus-pembrolizumab-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-outcomes-of-hepatosplenic-t-cell-lymphoma-mayo-clinic-experi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-program-addressing-multi-level-barriers-to-completion-of-hereditary-cancer-genetic-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-incidence-and-mortality-rates-of-bladder-cancer-in-older-adults-using-autoregressive-int 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-disparities-in-hpv-related-cancer-outcomes-insights-into-social-determinants-of-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-obesity-in-postoperative-outcomes-of-robot-assisted-radical-cystectomy-for-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-concurrent-pathogenic-variants-in-ibrca1i-breast-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/growing-burden-of-cancer-and-high-body-mass-index-in-the-united-states-from-1990-2021-a-benchmarkin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-single-institution-application-of-a-deep-learning-based-radiomic-score-in-metastatic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microrna-based-biomarkers-of-outcome-in-soft-tissue-sarcoma-treated-with-hypofractionated-preoperati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impacts-on-prognosis-of-the-relationship-between-decline-in-renal-function-associated-with-pemet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-combined-artificial-intelligent-system-for-lung-cancer-stage-prediction-and-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-margin-mutation-dissemination-patterns-in-iegfri-l858r-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rituximab-maintenance-on-outcomes-in-follicular-lymphoma-an-indian-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-iruplinalkib-in-resectable-ialki-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-fruquintinib-monotherapy-and-combination-therapy-in-chinese-patients-with-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-survival-analysis-across-different-age-groups-in-elderly-patients-with-es-sel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-estrogen-receptor-er-and-progesterone-receptor-pr-expression-levels-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-sr-8541a-in-combination-with-botensilimab-and-balstilimab-in-subjects-with-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-risk-stratification-in-breast-cancer-a-10-year-follow-up-of-a-single-institution-prospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reported-side-effects-from-treatment-in-a-prospective-phase-ii-randomised-trial-evaluating-local-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-early-detection-of-lung-cancer-methylation-anchor-probe-for-low-signal-enrichment-maple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-caprine-herpes-virus-1-cphv-1-on-cell-viability-and-chemosensitivity-in-breast-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-bintrafusp-alfa-m7824-in-patients-with-gastrointestinal-tumors-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-to-pediatric-oncology-clinical-trials-identifying-modifiable-enrollment-barriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-in-real-world-settings-for-multiple-primary-malignancies-in-prostate-cancer-comparison-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-peripheral-treg-expansion-after-sbrt-combined-with-low-dose-radiotherapy-to-predict-subsequent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-advanced-practice-nurses-and-telemonitoring-in-the-management-of-immune-mediated-adve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-autoimmune-disease-on-toxicity-and-outcomes-after-idecabtagene-vicleucel-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-patients-with-early-stage-non-small-cell-lung-cancer-receiving-timely-testing-for-the-alk-rearra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-timeliness-of-first-appointment-with-medical-oncology-a-quality-improvement-initiative-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diagnostic-workup-location-on-time-to-treatment-for-patients-with-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-high-grade-prostate-cancer-in-an-inner-city-population-analysis-of-commonly-dispen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiles-and-treatment-outcomes-in-young-adults-with-stage-iv-non-small-cell-lung-cancer-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ikrasi-ipg12ci-inhibitors-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-prior-treatment-tx-on-the-clinical-activity-of-imetelstat-ime-in-transfusion-dependent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-static-and-dynamic-risk-assessment-in-hma-treated-mds-patients-undergoing-stem-cell-transp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-analyzing-the-efficacy-and-safety-of-datopotamab-deruxtecan-dato-dxd-in-previously 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-evaluating-the-effectiveness-of-blue-button-a-tool-for-institution-agnostic-ehr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chemotherapy-on-financial-toxicity-in-african-american-breast-cancer-patients-early-findi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-pancreatic-cancer-treatment-the-role-of-pre-diagnosis-healthcare-utili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-role-of-sodium-glucose-cotransporter-2-inhibitors-in-hepatocellular-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-radiotherapy-planning-skills-through-structured-deliberate-practice-and-artificial-intelli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lactylation-mediated-igf2bpsrmrp-axis-and-effects-on-bladder-cancer-progression-through-the-regulat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-evaluation-of-the-nilotinib-paclitaxel-combination-in-patients-with-rare-solid-tumors-rapid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relevance-and-specificity-of-the-french-cian-lung-cohort-for-clinical-research-analyses-in-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-phase-ii-randomized-placebo-controlled-study-investigating-the-combination-of-yiv-906 2026-08-24 monthly 0.7 https://rjrindex.com/articles/midpoint-mri-as-an-early-predictor-of-responses-to-neoadjuvant-chemotherapy-in-patients-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-durvalumab-combined-with-various-chemotherapy-regimens-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapeutic-response-score-to-predict-prognosis-for-unresectable-hepatocellular-carcinoma-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-variant-interpretation-in-hereditary-cancer-testing-with-rna-analysis-from-residual-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-survival-disparities-in-primary-central-nervous-system-cns-lymphoma-an-analysis-of-rac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-preventive-breast-cancer-screening-findings-from-a-national-dataset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-circulating-tumor-dna-ctdna-and-disease-status-in-soft-tissue-sarcoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-early-recognition-and-treatment-of-immune-related-myositis-and-myasthenia-gravis-reduce-mortali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chinese-medicine-compound-fufang-ejiao-syrupfor-symptom-burden-of-cancer-related-fatigu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-making-inroads-into-advanced-endometrial-cancer-management-a-single-center-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-medicaid-recipients-with-early-onset-breast-cancer-an-analysis-of-the-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lobaplatin-based-chemotherapy-with-immunotherapy-as-first-line-treatment-in-patients-with-advanced-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-healthtree-cure-hub-registry-a-patient-centered-multicenter-approach-to-advancing-multiple-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-cancer-medications-shortage-on-the-survival-of-patients-with-lung-cancer-a-multicenter-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-immunotherapy-in-metastatic-uveal-melanoma-a-retrospective-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adela-a-double-blind-placebo-controlled-randomized-phase-3-trial-of-elacestrant-ela-everolimu-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-pd-1pd-l1-inhibitors-in-non-small-cell-lung-cancer-in-elderly-patients-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-test-utilization-in-the-first-6-months-after-initiating-mrd-testing-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-gaps-in-colorectal-cancer-screening-research-in-the-arab-world-a-16-year-bibliometric-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-adjuvant-dc-cik-following-high-dose-ifn-versus-high-dose-ifn-or-anti-pd1-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-plasma-ctdna-mutational-profile-and-heterogeneity-in-renal-cell-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-diagnostic-technology-for-the-isolation-and-analysis-of-live-myeloma-cells-from-the-blood-of-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-a-novel-rna-m6a-regulatory-gene-expression-signature-with-proliferation-and-disease-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-immune-related-adverse-events-a-retrospective-analysis-from-a-single-center-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pembrolizumab-carboplatin-paclitaxel-and-radiation-for-the-treatment-of-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eribulin-plus-pyrotinib-in-trastuzumab-resistant-her2-positive-advanced-breast-cancer-a-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azur-4-a-phase-2-open-label-randomized-study-of-neoadjuvant-dostarlimab-plus-capecitabine-plus-ox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-plus-anlotinib-in-patients-with-untreated-egfr-mutated-advanced-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-ifn-alpha-2b-as-adjuvant-treatment-for-acral-melanoma-a-retrospective-analysis-of-113-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-digital-platforms-accelerate-education-and-adoption-of-newly-implemented-treatment-guideli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-source-modular-ai-coupled-with-agentic-ai-for-comprehensive-breast-cancer-note-generation-and-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-tepotinib-and-immune-checkpoint-inhibitor-therapy-for-met-exon-14-skipping-nscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/human-compared-to-ai-a-single-blind-evaluation-of-spanish-language-translation-quality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-patients-with-tenosynovial-giant-cell-tumor-real-world-results-from-an-observational-regi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-trk-fusion-thyroid-carcinoma-an-updated-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantum-mechanics-based-multi-tensor-aiml-discovery-and-validation-of-actionable-and-mechanisticall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-2-cycles-of-chemotherapy-as-first-line-treatment-for-advanced-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-decreased-treatment-intensity-in-patients-with-metastatic-colon-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-the-international-consensus-classification-icc-for-systemic-mastocytosis-and-the-may 2026-08-24 monthly 0.7 https://rjrindex.com/articles/luspatercept-in-patients-with-lower-risk-myelodysplastic-syndromes-mds-a-systematic-review-and-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospice-utilization-in-veterans-with-newly-diagnosed-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-pain-and-emergency-department-utilization-in-patients-with-newly-diagnosed-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-impact-of-bet-inhibition-on-immune-cell-death-checkpoints-in-mpn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-transit-and-radiotherapy-cost-effectiveness-approach-to-environmental-health-savings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prevalence-of-homologous-recombination-repair-alterations-hrra-and-poly-adp-ribose-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ceramides-and-response-to-dual-secondary-hormonal-therapy-in-metastatic-castration-resistant-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bilateral-germ-cell-tumor-of-the-testis-tgct-implications-for-a-stem-cell-versus-genetic-origin-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-chatgpt-perform-as-well-as-pharmacists-in-identifying-potentially-inappropriate-medications-pim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-medicare-reimbursement-for-urological-cancer-surgeries-in-male-genitourinary-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-citation-impact-and-social-media-engagement-in-cancer-pain-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-profitability-clinical-benefit-and-physicians-selection-of-cancer-drugs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-frontline-folfirinox-with-fluorouracil-based-and-gemcitabine-basedchemotherapies-in-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-heart-failure-hospitalizations-among-patients-with-malignant-carcinoid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-case-control-study-of-thermosensitive-embolic-agents-tempsle-and-microspheres-in-tace-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-anatomical-concept-and-standardized-technique-for-single-port-laparoscopic-para-aortic-lymphad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-tti-in-patients-with-colorectal-cancer-and-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-with-trifluridinetipiracil-monotherapy-or-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-with-or-without-toripalimab-followed-by-concurrent-chemoradiotherapy-for-loco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-multidisciplinary-intervention-based-on-a-supervised-training-program-on-cardiovascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-and-regional-disparities-in-young-onset-breast-cancer-age-specific-patterns-from-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-health-disparities-in-prostate-cancer-patients-with-and-without-venous-throm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multiomic-approach-for-detecting-clinically-significant-prostate-cancer-in-seminal-fluid-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isopsa-in-prostate-cancer-a-systematic-review-of-diagnostic-prognostic-and-economic-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-gleason-grade-group-psa-levels-and-prostatectomy-outcomes-for-the-optimize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persistent-racial-disparities-in-aml-survival-in-the-flt3-inhibitor-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-clinical-data-extraction-from-oncology-trials-using-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-credit-status-for-newly-diagnosed-metastatic-colorectal-cancer-patients-swo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-chemo-immunotherapy-as-a-novel-bridging-strategy-for-non-complete-responders-after-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-in-patients-with-stage-23-hrher2-negative-breast-cancer-bc-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-a-plasmid-dna-based-immunotherapy-encoding-the-htert-psma-and-wt1-ino-5401 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-efficacy-of-tarlatamab-in-patients-with-small-cell-lung-cancer-or-extrapulmona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palbociclib-in-patients-pts-with-ovarian-cancer-oc-with-cdkn2a-alterations-results-from-the-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ind241-a-canadian-cancer-trials-group-liquid-biopsy-informed-platform-trial-to-evaluate-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-physical-activity-on-survival-outcomes-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carcinoid-heart-disease-and-urinary-5-hiaa-in-patients-with-pancreatic-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immunotherapy-of-high-risk-neuroblastoma-patients-with-long-term-infusion-of-dinutuxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-vaginal-tampon-versus-swab-in-the-collection-of-vaginal-fluid-for-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-diabetes-and-tumor-mutational-burden-in-ovarian-fallopian-tube-and-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-analysis-guiding-adjuvant-therapy-in-patients-pts-with-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preliminary-efficacy-and-safety-results-of-neoadjuvant-phase-ii-study-of-anlotinib-plus-tisleliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-analysis-between-tumor-tissue-her2-status-by-immunohistochemistry-ihc-and-in-situ-hybr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-in-the-expression-of-gprc5d-between-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/creation-of-the-ideal-health-care-pathway-for-integrating-ctdna-testing-into-clinical-practice-throu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-small-cell-lung-cancer-sclc-pre-and-post-2018-a-seer-based-analysis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-thermal-therapy-to-promote-the-expansion-of-tumor-reactive-like-cx3cr1-sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-to-predict-immune-related-adverse-events-in-cancer-patients-treated-with-icis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-as-bladder-sparing-maintenance-treatment-after-neoadjuvant-chemotherapy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-culturally-tailored-educational-tool-designed-to-increase-access-to-somatic-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-open-label-phase-2-study-of-the-pd-1il-2-supa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cost-of-convenience-evaluating-economic-differences-in-sq-and-iv-biotherapeutic-formulations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-pathological-response-in-unresectable-hepatocellular-carcinoma-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-as-a-predictor-of-small-cell-transformation-in-prostatic-adenocarcinoma-a-seer-2000-2021-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-genomic-and-immune-microenvironment-differences-in-chinese-populations-revealing-potent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-large-language-models-to-extract-cancer-diagnosis-histology-grade-and-staging-from-unstruc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imneo-high-accuracy-neoantigen-prediction-through-ai-based-integrated-analysis-of-multiple-immunoge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-curcumin-and-standard-radiation-and-temozolomide-for-newly-diagnosed-high-grade-gliomas-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-keynote-365-cohort-i-pembrolizumab-pembro-plus-carboplatin-and-etoposide-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-microbiome-diversity-and-oral-human-papillomavirus-associated-differences-in-black-vs-white-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequoia-5-year-follow-up-in-arm-c-frontline-zanubrutinib-monotherapy-in-patients-with-del17p-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-as-a-surrogate-outcome-for-overall-survival-in-ovarian-cancer-maintenance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-contouring-of-couinaud-segments-on-ct-utility-for-volumetric-analysis-of-future 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anti-pd-1-combined-with-thymosin-and-sox-in-neoadjuvant-treatment-of-cstage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-clinical-trial-screening-with-a-comprehensive-large-language-model-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validating-a-semantic-similarity-approach-for-automated-data-extraction-in-phase-ii-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-antitumor-activity-of-sup177sup-lu-catelase-a-preliminary-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-ovarian-function-suppression-with-adjuvant-endocrine-therapy-on-survival-outcomes-in-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-adagrasib-ada-with-pembrolizumab-pembro-in-patients-pts-with-advancedmetastatic-kr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-decade-of-progress-trends-in-5-year-survival-across-17-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-circulating-tumor-cell-distribution-with-pd-l1-expression-in-baseline-and-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elegant-elacestrant-versus-standard-endocrine-therapy-et-in-women-and-men-with-node-positive-est-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcome-assessments-in-patients-with-tenosynovial-giant-cell-tumor-treated-with-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer-with-ugn-102-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insight-into-the-global-mortality-trends-due-to-prostate-cancer-among-the-under-55-population-an-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/15-year-survivorship-in-patients-with-metastatic-gastrointestinal-stromal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dauntless-1-a-phase-2-clinical-trial-to-evaluate-pmd-026-a-first-in-class-pan-rsk-inhibitor-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-sociodemographic-and-facility-related-determinants-of-immunotherapy-use-in-metastatic-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-idecabtagene-vicleucel-and-ciltacabtagene-autoleucel-in-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-cardiometabolic-comorbidities-and-their-role-in-triple-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-of-head-and-neck-cancer-in-sub-saharan-africa-insights-from-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-cetuximab-and-chemotherapy-in-recurrent-or-metastatic-head-and-neck-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-induction-chemoimmunotherapy-versus-induction-chemotherapy-in-patients-with-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immune-checkpoint-inhibitors-on-unplanned-emergency-department-consultations-in-mnsclc-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-steroid-sparing-agents-ssas-for-immune-related-adverse-events-iraes-in-patients-pts-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relative-lymphocyte-percentage-as-a-predictive-biomarker-for-immune-checkpoint-inhibitor-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-treatment-resistance-on-cspg4-expression-in-metastatic-melanoma-across-multiple-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-characteristics-of-clinical-trial-participation-and-its-impact-on-clinical-outcome-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-mk-3475a-in-relapsed-or-refractory-classic-hodgkin-lymphoma-or-primary-mediastinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-clinical-factors-with-outcomes-in-patients-with-localized-ewing-sarcoma-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-chemotherapy-induced-cardiotoxicity-among-african-american-women-with-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-histology-dependent-immunobiological-differences-in-metastatic-nsclc-implicatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-prediabetes-as-a-potential-risk-factor-for-breast-cancer-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-safety-and-biomarker-analysis-of-a-phase-2-study-of-lbl-007-alcestobart-an-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immune-checkpoint-inhibitors-ici-in-biliary-tract-cancer-btc-real-world-outcomes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-mastocytosis-a-study-of-trends-survival-and-second-primary-malignancies-among-adults-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-reported-adherence-to-cancer-therapy-development-and-validation-of-a-cancer-specific-dose-nona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-first-second-and-third-generation-tyrosine-kinase-inhibitors-in-chron 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-stem-cell-boost-for-poor-engraftment-following-allogeneic-hematopoietic-stem-cell-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-from-flex-utility-of-mammaprint-in-guiding-treatment-planning-for-patients-aged 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-hormone-therapy-usage-with-adverse-cardiovascular-events-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-clinical-trial-site-efficiency-and-unlocking-patient-access-to-clinical-trials-using-techn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-court-documented-major-adverse-financial-events-before-cancer-diagnosis-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uptake-of-targeted-therapy-in-a-large-cohort-of-patients-with-advanced-prostate-cancer-and-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-number-of-lymph-node-dissections-related-to-survival-of-patients-with-locally-advanced-esophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-chemotherapy-utilization-among-urban-upper-gi-malignancy-cancer-patients-at-a-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-mortality-length-of-stay-and-hospitalization-costs-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-anti-pd-l1-inhibitor-strategies-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fes-and-fdg-pet-imaging-performance-comparison-for-potential-use-in-biology-guided-radiotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-sup177sup-lu-jh020002-in-patients-with-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-dose-escalation-and-expansion-clinical-trial-to-evaluate-the-safety-pharmaco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-nivolumab-vs-docetaxel-as-second-line-treatment-in-advanced-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-data-from-phase-1b2-epcore-nhl-4-epcoritamab-epcor-in-chinese-patients-pts-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-tgfv-signaling-pathway-to-mitigate-tumor-metastasis-in-9p21-loss-urothelial-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-the-incidence-of-hodgkins-lymphoma-in-the-middle-east-and-north-africa-over-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-biological-networks-in-lung-adenocarcinoma-using-transcriptomic-analysis-to-identify-prognos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-and-dose-expansion-study-for-lncb74-a-b7-h4-targeted-antibody-drug-conjug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-plus-everolimus-as-first-line-treatment-for-advanced-non-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-irradiation-on-the-killing-effect-of-nk-cells-in-colon-cancer-through-mybtim3-axis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-postoperative-acute-kidney-injury-in-robotic-assisted-pulmonary-lobectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-inflammatory-biomarkers-as-predictors-of-outcomes-and-immune-related-adverse-events-irae 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-comparison-between-immunotherapy-and-conventional-chemotherapy-in-patients-with-advanced-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-ici-in-thymic-epithelial-tumors-tet-a-real-world-assessment-of-eff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-biomarkers-for-colorectal-cancer-in-a-nigerian-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-colorectal-liver-metastasis-and-insight-into-their-prognostic-value 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-nuclear-cd276-on-cd36-mediated-lipid-metabolism-reprogramming-on-tki-resistance-in-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-regorafenib-following-first-line-immune-checkpoint-inhibitor-failure-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-pemetrexed-plus-oxaliplatin-as-2-supndsup-line-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-palliative-care-utilization-in-advanced-head-and-neck-cancer-hospitalizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/out-of-touch-understanding-the-frequency-and-trajectory-of-chemotherapy-induced-neuropathy-peripher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-readmission-to-index-vs-non-index-hospitals-after-major-cancer-surgery-doe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-and-survival-outcomes-in-adolescent-and-young-adults-with-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/considering-the-caregiver-in-early-phase-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-large-language-model-llm-for-pan-cancer-automated-detection-of-anti-cancer-therapy-toxici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-immune-and-stromal-alterations-in-colorectal-cancer-with-diabetes-mellitu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-esr1-and-pik3ca-actionable-mutations-in-breast-cancer-using-liquid-biopsy-a-step-towar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-people-living-with-hiv-in-food-and-drug-administration-fda-oncology-pivotal-registrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumour-microbiome-and-immune-dysregulation-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ai-predictive-models-to-develop-thymic-tumor-specific-peptides-mimicking-col17a1-alterati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eter901-a-randomized-open-label-phase-iii-trial-of-anlotinib-in-combination-with-anti-pd-l1-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-kite-363-anti-cd19cd20-chimeric-antigen-receptor-car-t-cell-therapy-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-determinants-of-survival-in-pancreatic-neuroendocrine-tumors-a-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-different-hrd-assays-in-high-grade-serous-ovarian-cancer-in-greek-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-preoperative-plasma-insulin-like-growth-factor-1-igf-1-as-a-predictor-of-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-bisulfite-sequencing-of-cell-free-dna-to-investigate-molecular-contributors-to-racial-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-peptide-receptor-radionuclide-therapy-in-combination-with-capecitabine-and-temozolomide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-combined-with-lenvatinib-versus-hepatic-artery-infusion-chemotherapy-haic-for-neoadjuva-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-strategies-and-outcomes-of-inflammatory-myofibroblastic-sarcoma-insights-from-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-attribution-and-management-in-non-aggressive-bone-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reliable-detection-of-merkel-cell-polyomavirus-in-merkel-cell-carcinoma-by-whole-exome-next-generati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-palliative-treatments-among-disaggregated-hispanic-populations-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-care-on-the-management-and-outcomes-of-elderly-pancreatic-cancer-patients-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-prevention-of-cardiotoxicity-in-cancer-patients-treated-with-fluoropyrimidines-a-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-discordance-between-immunochemistry-of-mismatch-repair-proteins-and-next-generation-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changing-oncology-training-in-latin-america-a-mentorship-program-design-and-implementation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nimotuzumab-plus-ag-regimen-as-conversion-therapy-for-locally-advanced-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tobacco-use-and-sociodemographic-factors-on-mortality-in-pancreatic-cancer-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-clonal-competition-model-of-pdac-liver-metastasis-on-a-pan-carcinoma-gene-signature-of-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-radiographic-predictors-of-overall-survival-in-stage-ii-iii-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pembrolizumab-and-epacadostat-combination-therapy-in-metastatic-epithelial-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-choosing-hematologyoncology-as-a-career-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-nationwide-survey-of-gaps-in-oncology-residency-education-in-armenia-and-the-potential-role-of-jou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinician-perspectives-on-digital-and-computational-pathology-in-oncology-opportunities-and-challen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-regorafenib-combination-with-pd-1-inhibitors-vs-regorafenib-monotherapy-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-relationship-between-the-number-of-hematoporphyrin-intravesical-perfusion-photodynam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-liquid-biopsy-in-predicting-recurrence-in-patients-with-operable-gastroesophageal-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-tumor-genomics-and-clinical-outcomes-in-in-adolescent-and-young-adult-aya-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-artificial-intelligence-in-the-development-of-patient-oriented-oncology-information 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-difference-of-clinical-and-molecular-characteristics-between-hr-positiveher2-positive-and-hr-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-early-sepsis-treatment-decision-algorithm-in-children-and-adolescents-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-utilization-of-active-surveillance-treatment-and-survival-in-prostate-cancer-insights-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-therapy-response-in-irasi-mutated-myeloid-malign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-mobile-mammography-versus-urban-hospital-based-breast-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/receipt-of-guideline-concordant-oncologic-care-between-older-hiv-positive-and-older-hiv-negative-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/desensitization-protocols-for-platinum-based-chemotherapy-in-metastatic-cervical-cancer-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffuse-large-b-cell-lymphoma-patients-with-early-post-diagnosis-mortality-at-a-quaternary-care-cent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genital-cancer-mortality-in-comorbid-vs-non-comorbid-populations-a-nationwide-trend-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cerebrovascular-disease-related-mortality-in-older-adults-with-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-in-nsclc-uncovering-disparities-and-advancing-health-equity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-disability-adjusted-life-years-dalys-of-pancreatic-cancer-among-individuals-age 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-maintenance-therapy-with-metformin-and-temozolomide-for-newly-diagnosed-glioblas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neuroradiologists-input-on-peer-review-meetings-for-cns-radiotherapy-treatment-planning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-inequalities-in-mortality-due-to-hepatocellular-cancer-in-male-patients-with-alcoholic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-the-colorectal-cancer-alliances-digital-screening-quiz-in-advancing-crc-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-scoping-review-of-uptake-and-interventions-in-specialty-and-non-primary-care-clinical-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-lung-cancer-screening-gaps-in-refugee-populations-insights-from-a-retrospective-cohort-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-trends-in-brain-and-cns-cancer-across-high-income-countries-a-benchmarking-study-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utilization-of-palliative-care-services-by-patients-with-glioblastoma-a-cross-sectional-study-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-case-control-study-on-osteoporosis-risk-in-cancer-patients-receiving-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-plus-chemotherapy-versus-chemotherapy-alone-for-the-treatment-of-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-after-osimertinib-dose-reduction-discontinuation-in-1l-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-plasma-cell-leukemia-in-the-us-incidence-mortality-and-survival-predictors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-a-multicenter-open-label-phase-2-study-evaluating-the-efficacy-and-safety-of-tis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regulation-of-tumor-associated-fibroblasts-by-tacstd2-in-esophageal-squamous-cell-carcinoma-and-its 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-triple-oral-metronomic-chemotherapy-in-patients-with-advanced-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-apx-343a-nox-inhibitor-targeting-caf-mediated-immunosuppression-as-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-combination-of-pd-1-inhibitor-with-chemotherapy-salvage-chemoradiotherapy-for-local-primary-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-or-bortezomib-with-lenalidomide-and-dexamethasone-vrd-for-initial-therapy-of-newly-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-study-using-ai-based-imaging-analysis-technology-to-continuously-monitor-sarcopenia-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-use-and-liver-cancer-mortality-in-the-us-1999-2020-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inconsistent-housing-support-for-oncologic-patients-at-nci-designated-cancer-centers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-and-increasing-awareness-of-social-determinants-of-health-of-patients-with-cancer-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-oncology-fellows-insights-to-enhance-cancer-care-a-quality-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-zanubrutinib-treatment-patterns-in-mantle-cell-lymphoma-mcl-among-us-community-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitamin-d-deficiency-in-prostate-cancer-prevalence-in-a-sun-rich-climate-and-the-influence-of-andro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-interest-and-satisfaction-with-integrative-oncology-approaches-among-hospitalized-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-on-genomic-features-of-prostate-cancer-patients-with-and-without-treatment-emer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-brca-alterations-on-androgen-receptor-pathway-inhibition-treatment-outcome-in-advanced-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-access-to-breast-cancer-clinical-trials-with-breastcancertrialsorg-and-a-dedicated-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-therapy-related-aml-t-aml-with-venetoclax-based-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-hepatocellular-carcinoma-admissions-comorbidities-and-outcomes-a-nationwide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-hbv-related-vs-hcv-related-hepatocellular-carcinoma-under-targeted-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/language-matters-impact-of-medical-interpretation-on-lung-cancer-screening-adherence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-and-inclusiveness-of-health-insurance-information-in-generative-artificial-intelligence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-digital-literacy-gap-empowering-patients-and-care-partners-through-the-digital-sherpa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operational-feasibility-and-impact-of-a-digital-platform-for-symptom-management-in-oncology-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cancer-study-enrollments-between-urban-rural-frontier-and-remote-participants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-fih-study-of-novel-oral-serd-fwd1802-in-patients-with-erher2-unresectable-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognosis-of-pulmonary-lymphoepithelioma-like-carcinoma-a-multicentre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-pik3ca-mutations-for-response-to-cdk46-inhibitors-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-iegfri-assessment-in-plasma-and-tissue-samples-in-early-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-four-quadrant-enhanced-coloanal-anastomosis-fqecaa-for-patients-receiving-intersphincteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-with-mfolfoxiri-combined-with-camrelizumab-and-bevacizumab-for-microsatellite-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taps-chemistry-a-novel-ultrasensitive-pan-cns-cancer-liquid-biopsy-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-invasive-fungal-infections-in-patients-with-chronic-lymphocytic-leukemia-treated-with-bruton 2026-08-24 monthly 0.7 https://rjrindex.com/articles/setting-a-precedent-development-of-a-core-outcome-set-for-locoregional-treatment-outcome-reporting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-assessment-using-urinary-tumor-dna-utdna-to-identify-potential-candidates-for-repeat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-furmonertinib-combined-with-bevacizumab-and-pemetrexed-in-non-small-cell-lung-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-prolgolimab-and-nurulimab-versus-nivolumab-and-ipilimumab-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-and-dynamic-circulating-tumor-cell-monitoring-in-advanced-lung-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-reflectance-confocal-microscopy-for-noninvasive-diagnosis-and-accurate-surgical-margin-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-expression-on-circulating-tumor-cells-and-ctc-clusters-as-a-minimal-cellular-disease-in-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-neoadjuvant-keynote-522-regimen-in-triple-negative-breast-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-versus-doublet-therapy-in-older-patients-with-metastatic-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-circulating-tumor-dna-ctdna-to-evaluate-need-for-additional-targeted-therapies-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plp-driven-exosomal-breakthroughs-advancing-immune-solutions-for-complex-tumor-microenvironments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-imaml2i-fusions-as-oncogenic-drivers-in-human-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-metastatic-germ-cell-tumors-with-highly-elevated-human-chor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-ipilimumabnivolumab-for-refractory-merkel-cell-carcinoma-a-single-institution-experien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-the-anti-tumor-activity-and-mechanism-of-action-of-tara-002-and-bcg-in-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-assessment-in-patients-with-early-stage-classical-hodgkin-lymphoma-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-complications-in-patients-with-diffuse-large-b-cell-lymphoma-receiving-axic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-workers-and-womens-perspectives-on-barriers-to-cervical-cancer-screening-and-treatment-upta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-dexamethasone-dex-with-outpatient-step-up-dosing-sud-of-bispecific-antibodies-bsab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-financial-toxicity-among-cancer-patients-on-immunotherapy-and-targeted-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-i-trial-of-adjuvant-personalized-cancer-vaccine-tg4050-in-resected-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-oncology-clinical-trial-matching-through-multi-agent-ai-and-an-oncology-specific-knowle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-an-open-label-single-arm-phase-ii-trial-investigating-the-efficacy-and-safety-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-safety-and-efficacy-of-pdl1v-pf-08046054-a-vedotin-based-adc-targeting-pd-l1-in-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer-ecgejc-following-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-disitamab-vedotin-rc48-in-combination-with-tislelizumab-and-bevacizumab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-to-neoadjuvant-chemotherapy-in-early-stage-male-breast-cancer-across-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-fellow-led-tumor-board-to-enhance-learning-and-support-in-fellow-continuity-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-donafenib-combined-with-anti-pd-1-antibody-plus-transarterial-chemoemboli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-during-anti-pd-1-based-therapy-to-predict-clinical-outcomes-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-analysis-and-overall-survival-update-of-phase-ii-trident-study-durvalumab-plus-olaparib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-survival-prediction-in-primary-urinary-tract-melanoma-pmut-using-a-nomogram 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-in-patients-pts-with-her2-expressing-advanced-gynecological-cancers-gynecol-c-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-bortezomib-lenalidomide-and-dexamethasone-isa-vrd-in-newly-diagnosed-multiple-myelom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inb-200-phase-1-study-of-gene-modified-autologous-gamma-delta-ghd-t-cells-in-newly-diagnosed-gliob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-combined-with-chemotherapy-in-the-first-line-treatment-for-patients-with-stage-ivb-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantum-wild-a-phase-3-randomized-double-blind-placebo-controlled-trial-of-quizartinib-in-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-results-of-the-randomized-phase-3-keynote-412-trial-of-pembrolizumab-pembro-or-placebo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-ezh12-inhibitor-valemetostat-tosylate-ds-3201b-in-pediatric-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-as-first-line-treatment-for-unresectable-locally-advancedmetastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subcutaneous-daratumumab-dara-bortezomiblenalidomidedexamethasone-vrd-with-dara-lenalidomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/huntingtons-disease-as-a-protective-factor-for-non-melanoma-skin-cancer-a-retrospective-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibi354-anti-her2-antibody-drug-conjugate-adc-in-patients-pts-with-her2-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-phase-1-clinical-trial-of-epcam-car-t-cell-therapy-in-patients-with-gastrointestinal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brazilian-society-of-surgical-oncology-realities-and-challenges-of-surgical-oncologists-in-palliati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-trade-study-a-phase-2-trial-to-assess-the-tolerability-of-abemaciclib-dose-escalation-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-trastuzumab-deruxtecan-t-dxd-in-her2-positive-and-low-metastatic-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-association-of-pik3ca-in-hpv-driven-head-and-neck-squamous-cell-carcinoma-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-responses-to-sync-t-therapy-in-situ-personalized-cancer-vaccination-with-intratumoral-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prospective-study-on-compassionate-and-off-label-novel-anticancer-therapies-in-children 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-outcomes-in-metastatic-renal-cell-carcinoma-the-role-of-international-metastatic-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-radiomic-features-with-disease-free-survival-following-neoadjuvant-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-marital-status-on-survival-in-patients-with-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-attitudes-and-concerns-about-artificial-intelligence-applications-in-patients-with-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-toxicity-of-intravesical-sequential-gemcitabine-and-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bevacizumab-in-combination-with-radiotherapy-and-temozolomide-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-envafolimab-in-combination-with-recombinant-human-endostatin-and-chemotherapy-for-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ib-t101-an-outlast-car-t-product-for-the-treatment-of-cd70-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-mortality-in-brazil-insights-from-over-25-years-of-data-and-the-impact-of-limited-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-clinical-trial-enrollment-in-glioblastoma-patients-a-retrospective-study-at-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-and-racial-and-gender-disparities-in-adult-t-cell-leukemialymphoma-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-cervical-cancer-screening-among-sexual-and-racialethnic-minorities-during-the-covid-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-open-label-safety-tolerability-and-efficacy-study-of-hc-7366-in-combination-with-belz-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-31-gene-expression-profile-as-a-guide-to-better-risk-aligned-care-decisions-for-patients-with-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerator-based-boron-neutron-capture-therapy-a-randomized-controlled-trial-for-refractory-recurr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-and-trend-of-tracheal-bronchus-and-lung-cancer-attributable-to-residential-radon-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipelife-phase-iii-double-blind-trial-of-icannabis-sativai-extract-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-tracheal-bronchus-and-lung-cancer-in-high-income-north-america-trends-from-1990-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-study-of-neoadjuvant-regn7075-cemiplimab-chemotherapy-chemo-vs-cemiplimab-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-clonal-hematopoiesis-of-indeterminate-potential-chip-in-cancer-prevalence-clonal-dyna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-study-of-a-first-in-class-hif1-and-hif2-dual-inhibitor-r01-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-sup64sup-cu-labeled-cetuximab-in-immuno-pet-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-extracellular-vesicle-based-assay-for-early-detection-of-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-the-automated-heart-health-assessment-ah-ha-tool-on-cardiovascular-health-improve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-multisite-randomized-trial-of-bright-ideas-young-adults-efficacy-of-problem-solving-sk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomic-evaluation-of-her-2-expression-and-activation-in-tumors-that-are-rna-overexpressed-but-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-incorporating-symptom-burden-with-mortality-as-a-composite-outcome-on-accuracy-and-bias-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-folfirinox-versus-gemcitabine-based-regimens-for-treatment-of-metastatic-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/food-insecurity-dietary-quality-and-cardiovascular-risk-in-early-childhood-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/slamf8-as-a-potential-therapeutic-target-for-modulating-tumor-associated-macrophages-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-of-complement-activation-signatures-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-designed-eniluracil-capecitabine-phase-2-trial-in-advanced-or-metastatic-breast-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-and-tremelimumab-combination-therapy-versus-durvalumab-monotherapy-in-metastatic-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-safety-and-effectiveness-of-cemiplimab-in-combination-with-platinum-doublet-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-immune-checkpoint-inhibitor-related-adverse-events-in-the-geriatric-lung-cancer-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-health-co-morbidities-on-outcomes-in-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-outcomes-in-merkel-cell-carcinoma-a-nationwide-analysis-of-sociodemographic-characterist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profile-and-disparity-of-care-in-metastatic-non-small-cell-lung-cancer-in-a-low-middle-inc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-relationship-between-tumor-mutational-burden-tmb-and-microsatellite-instability-msi-in-bilia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-enrollment-in-a-clinical-trial-on-treatment-outcomes-of-patients-with-pancreas-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-survival-outcomes-among-adolescent-and-young-adult-patients-with-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-and-prognostic-applications-of-blood-cadherin-17-ca17-and-ca199-on-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nanoparticle-polymeric-micellar-paclitaxel-combined-with-gemcitabine-in-first-line-treatment-of-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-analysis-comparison-of-radical-antegrade-modular-pancreatectomy-ramps-and-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-differential-expression-of-genes-with-survival-and-relapse-in-patients-treated-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-case-based-learning-program-in-medical-oncology-a-trainee-led-feasibility-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-next-generation-sequencing-in-metastatic-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-postoperative-circulating-tumor-dna-and-tumor-markers-in-resected-pancreatic-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tagraxofusp-and-low-intensity-chemotherapy-for-the-treatment-of-cd123-positive-relapsed-or-refractor-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-primary-tumor-resection-on-survival-outcomes-in-de-novo-metastatic-urothelial-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-propensity-matched-analysis-of-second-line-2l-folfiri-ram-versus-ram-pac-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-cancer-registry-in-turkey-2002-2024-tpog-and-tphd-the-data-from-the-last-23-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-twins-as-simulations-of-individual-cancer-pathophysiology-through-extensive-tumor-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-multi-center-phase-i-study-of-utidelone-capsule-a-novel-oral-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-concentric-partial-response-pattern-as-a-predictor-of-pathological-complete-response-in-early-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-concurrent-chemoradiotherapy-for-locally-recurrent-esophageal-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-immunotherapy-responders-in-hepatocellular-carcinoma-patients-with-stable-disease-multi-om 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-homologous-recombination-deficiency-in-korean-patients-with-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-lipidomics-analysis-of-early-and-late-stage-ovarian-cancer-serum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-a-prospective-multicenter-study-evaluating-a-combined-circulating-tumor-dna-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-burden-of-liver-malignancies-due-to-nash-an-analysis-of-gbd-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-clinical-trial-communication-skills-training-for-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lighting-up-pnet-creating-murine-models-with-a-novel-bioluminescent-cell-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-homologous-recombination-deficiency-in-different-molecular-subgroups-of-endometrial-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-cells-identified-in-the-peripheral-blood-of-patients-with-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-isolated-groin-recurrence-following-sentinel-lymph-node-biopsy-in-primary-node-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-itp53i-somatic-mutations-on-prognosis-in-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-burden-of-chimeric-antigen-receptor-t-cell-therapy-a-national-inpatient-sample-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-and-sitravatinib-as-adjuvant-therapy-for-hepatocellular-carcinoma-patients-at-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-damage-measurements-as-a-potential-biomarker-for-immunotherapy-response-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-different-formulations-of-goserelin-on-testosterone-suppression-in-patients-with-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipdsim-an-interpretable-model-to-assess-individual-clinical-antagonism-in-combination-therapies-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-beam-radiation-therapy-for-salvage-after-focal-therapy-as-primary-treatment-in-prostate-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-extracapsular-extension-and-seminal-vesicle-invasion-in-prostate-cancer-using-preopera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-post-operative-opioid-fills-after-cancer-directed-surgery-among-medicare-beneficiaries-by-race 2026-08-24 monthly 0.7 https://rjrindex.com/articles/active-cancer-in-the-era-of-covid-19-a-multivariable-meta-analysis-vs-non-cancer-controls-with-vari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-unmet-needs-in-radiation-induced-nausea-and-vomiting-after-moderately-emetogenic-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adherence-and-tolerability-of-flt3-inhibitors-as-post-allogeneic-transplant-maintenance-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-allostatic-load-al-and-residential-segregation-with-breast-biopsy-outcomes-after-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-variables-associated-with-prolonged-survival-in-aml-with-tp53-aberration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-primary-care-clinics-for-comprehensive-care-of-high-risk-adolescent-and-young-adult-aya-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomised-clinical-trial-to-improve-healthy-lifestyle-adherence-in-prostate-cancer-patients-under 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-do-health-concerns-present-in-cancer-survivors-who-require-interpreters-database-analysis-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-the-mortality-trends-due-to-gastric-cancer-across-204-regions-worldwide-1990-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-first-in-human-fih-phase-i-study-of-ptx-912-in-patients-with-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-gastric-cancer-trends-a-retrospective-analysis-of-tumor-location-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-incidence-of-gastric-cancer-among-older-adults-70-from-1990-to-2021-across-204 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-cancer-care-outcomes-and-social-determinants-of-health-in-the-rio-grande-valley-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/publication-and-data-sharing-of-completed-nci-cooperative-group-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-zanubrutinib-treatment-patterns-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-breast-cancer-survivorship-needs-assessment-tool-an-asco-quality-training-progr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-homologous-recombination-repair-gene-mutations-on-survival-in-metastatic-castration-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-the-amivantamab-to-lazertinib-versus-lazertinib-alone-in-egfr-mutant-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-informed-immune-biomarker-for-trastuzumab-benefit-in-her2-breast-cancer-va 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-significance-of-relative-dose-intensity-of-capox-therapy-in-epidemiological-evaluation-of-gastri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-free-dna-derived-from-active-chromatin-as-a-predictive-biomarker-for-clinical-benefit-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-gender-based-differences-in-the-molecular-profile-of-myeloid-neoplasms-insights-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-survival-after-de-escalated-neoadjuvant-therapy-in-her2-early-breast-cancer-a-pooled 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-fairness-assessment-of-machine-learning-models-for-predicting-30-day-readmission-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generative-artificial-intelligence-ai-for-predictive-analysis-can-ai-estimate-the-likelihood-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1-clinical-trial-of-ini-4001-a-novel-tlr78-agonist-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-prognostic-model-to-optimize-the-timing-of-docetaxel-doc-following-an-androgen-receptor-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-mnsgcts-with-and-without-teratoma-in-the-primary-tumor-an-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-mental-illness-and-physical-abuse-for-predicting-cannabis-use-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-to-evaluate-safety-and-preliminary-efficacy-of-the-wee1-inhibitor-debio-0123-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-explores-gjb2-mediated-interactions-in-cancer-associated-pericyte-subgroups-tha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-raf-and-mek-inhibition-in-solid-cancers-with-kinase-impaired-braf-mutations-soratram-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-trametinib-in-patients-with-advanced-solid-tumors-harboring-genomic-alterations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-tas-102-and-irinotecan-in-oxaliplatin-and-fluoropyrimidine-pre-treated-metastatic-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-fruquintinib-in-combination-with-folfiri-as-second-line-treatment-for-ras-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sample-characteristics-on-rna-based-next-generation-sequencing-ngs-for-fusion-gene-detec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-q61h-mutational-subtype-on-the-response-to-standard-first-line-treatment-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-minimization-analysis-of-treatment-with-intravenous-or-subcutaneous-trastuzumab-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-versus-local-standard-of-care-in-patients-with-grade-2-3-meningioma-no-longer-eligible-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/environmental-pfas-exposure-as-an-understudied-social-determinant-of-health-for-endometrial-cancer-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-muscle-invasive-bladder-cancer-burden-the-impact-of-bcg-shortage-and-its-interaction-with-epide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-trial-of-adjuvant-ado-trastuzumab-emtansine-t-dm1-for-patients-with-her2-positi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-different-induction-therapy-for-locally-advanced-marginal-resectable-and-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-a-pooled-synthetic-long-peptide-mutant-kras-vaccine-in-patients-with-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-and-refinement-of-society-of-immunotherapy-of-cancer-sitc-definitions-for-pd-l1-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-toripalimab-plus-chemotherapy-and-radiotherapy-for-treatment-naive-advanced-es 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-racialethnic-inequities-in-uptake-of-psma-pet-imaging-among-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skewed-offspring-distribution-of-itp53i-pathogenic-variants-in-israeli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-proportion-and-survival-of-stage-iv-breast-cancer-between-2010-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-mutational-profiles-and-their-correlation-with-organ-specific-metastases-in-mss-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-palliative-care-utilization-among-children-with-late-stage-bone-and-sof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-juice-pir-1245-a-promising-prognostic-biomarker-for-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socio-behavioral-needs-and-prostate-and-breast-cancer-mortality-rates-in-african-americans-hispanic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-oncology-clinician-and-staff-experiences-with-substance-use-disorders-among-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-care-of-patients-with-hrher2-early-breast-cancer-at-high-risk-of-recurrence-through-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-factors-and-severity-of-phenotypic-frailty-in-the-elevate-longitudinal-cohort-of-older-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-4-1bbl-ox40l-fusion-protein-on-the-anti-tumor-activity-of-car-t-cells-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysphagia-in-cancers-of-the-lip-oral-cavity-and-pharynx-patients-impact-on-cachexia-hospitalizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymidine-kinase-activity-tka-as-independent-predictor-of-outcome-in-metastatic-breast-cancer-mbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glycosylation-patterns-of-tumor-derived-small-extracellular-vesicles-and-hypoxia-signatures-in-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-value-of-pet-ct-for-early-detection-of-mronj-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-study-to-evaluate-the-tolerability-safety-pharmacokinetics-and-efficacy-of-ecirucicl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-anterior-tongue-carcinoma-beyond-tnm-indian-multi-centric-real-world-data-on-molecular-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-ondansetron-oral-soluble-film-for-the-prevention-of-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-weight-and-body-composition-on-survival-and-toxicities-in-patients-receiving-cdk46-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perilipin-5-as-mediator-of-high-fat-diet-induced-hepatocellular-carcinoma-immune-escape-by-stabiliza 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-biomarker-testing-for-targetable-alterations-among-patients-with-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-race-and-ethnicity-in-high-impact-lung-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bxq-350-a-novel-sphingolipid-metabolism-modulator-on-neuronal-environments-through-modul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-study-design-that-promotes-diversity-in-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-causal-modeling-to-uncover-cell-cell-communication-dynamics-in-the-tumor-microenvironment-dur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-and-transcriptional-consequences-of-mtap-loss-in-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-landscape-of-liver-metastases-in-advanced-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gbc-11004-an-ai-driven-novel-kinase-target-with-potential-to-overcome-osimertinib-resistance-in-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-toxicity-in-the-curative-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-heart-cross-talk-cytokine-release-pattern-from-anthracycline-treated-cancer-cell-lines-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-i-study-of-kl590586-in-patients-with-advanced-ret-mutant-medullary-thyroid-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-neoadjuvant-imaging-for-prediction-of-pathologic-complete-response-to-keynote-522-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transoral-robotic-surgery-tors-and-de-escalated-adjuvant-therapy-for-human-papillomavirus-related 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-waldenstrom-macroglobulinemia-wm-patients-who-discontinue-bruton-tyrosine-ki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-mediating-role-of-inflammation-in-the-association-between-platinum-based-chemotherapy-and-cardio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-combined-with-atezolizumab-plus-bevacizumab-versus-transarterial-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-trends-in-telehealth-utilization-by-medical-oncology-practices-at-stanford-medicine-and-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-telemedicine-on-access-to-care-in-surgical-oncology-clinics-distance-and-time-to-visit-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-diagnosis-management-and-outcomes-in-transgender-nonbinary-and-gender-diverse-indi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-elective-neck-irradiation-in-pt3-t4-oral-squamous-cell-carcinoma-with-a-pn0-neck-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-negativity-neg-in-patients-pts-with-relapsed-or-refractory-multip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ribbon-um-treatment-individualisation-by-ebv-stratification-in-nasopharyngeal-carcinoma-npc-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implication-of-mdm2-amplification-in-advanced-biliary-tract-cancer-btc-a-propensity-scor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rc48-adc-combined-with-radiotherapy-and-immunotherapy-as-salvage-therapy-for-advanced-solid-tumors-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-results-of-terbium-161-sup161sup-tbtb-psma-iampt-rad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-epitope-mrna-vaccine-for-effective-immunotherapy-in-esophageal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-adc-trastuzumab-rezetecan-shr-a1811-in-her2-positive-breast-cancer-with-brain-metastases-upd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/commission-on-cancer-lung-cancer-surgery-quality-metric-and-overall-survival-in-a-population-based-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-biomarker-results-of-nure-combo-a-phase-2-study-of-neoadjuvant-nivolumab-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-tumor-dna-ctdna-variant-allelic-frequency-vaf-with-outcomes-on-matche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unlocking-the-potential-of-zolbetuximab-in-cldn182-positive-gastric-cancer-a-comprehensive-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-marking-techniques-for-target-lymph-nodes-in-2596-patients-with-node-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-monotherapy-efficacy-of-novel-immune-checkpoint-blockade-gv20-0251-anti-igsf8-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-combined-treatment-with-dupilumab-anti-il-4ra-and-cemiplimab-anti-pd-1-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folate-receptor-alpha-fra-folr1-expression-and-persistence-in-ovarian-cancer-in-clinical-trial-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promising-early-results-of-mhb088c-b7-h3-adc-in-patients-pts-with-metastatic-castration-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ctim-76-a-claudin-6-cldn6-directed-bispecific-antibody-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-gynecologic-melanomas-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-epigenomic-profiling-to-reveal-molecular-correlates-of-response-and-resistance-to-177lu-psma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-trial-of-microbubble-enhanced-transcranial-focused-ultrasound-mb-fus-with-monthly-adju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-car-t-and-bispecific-antibodies-in-follicular-lymphoma-a-comparative-efficacy-asse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1-inhibitor-combined-with-nab-paclitaxel-and-cisplatin-in-resectable-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-clinical-trial-of-ag01-a-recombinant-monoclonal-antibody-to-progranulinglyc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-induction-chemo-immunotherapy-on-the-chance-for-re-irradiation-in-high-risk-recurrent-naso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tub-030-a-novel-adc-targeting-5t4-a-phase-iiia-multi-center-first-in-human-clinical-trial-5-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-human-ai-teams-on-oncology-prescreening-final-analysis-of-a-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-in-vivoengineered-car-macrophages-on-physical-barriers-tumor-regression-and-immune-memory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lrrc15-radioimmunotheranostics-targeting-tgfv-driven-resistance-in-immune-excluded-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-in-her2-expressing-salivary-gland-cancers-preliminary-efficacy-and-safety-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-polatuzumab-vedotin-plus-rituximab-cyclophosphamide-doxorubicin-and-prednis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neoadjuvant-lenvatinib-plus-pembrolizumab-in-merkel-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/famitinib-for-familial-adenomatous-polyposis-associated-aggressive-desmoid-tumors-32-month-follow-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-and-ipilimumab-in-treating-metastatic-colorectal-cancer-mcrc-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/project-optimus-principles-challenges-and-a-paradigm-shift-in-dose-optimization-for-cancer-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-basket-trial-of-ado-trastuzumab-emtansine-for-patients-with-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-early-versus-late-palliative-care-referral-pcr-on-healthcare-utilization-in-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supervised-home-based-exercise-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-on-maint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cardiac-evaluation-in-patients-with-advanced-lung-cancer-who-received-immune-checkpoint-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-and-management-experience-summary-of-immune-related-adverse-events-in-136-gynecologic-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enlonstobart-in-patients-with-pd-l1-positive-recurrentmetastatic-cervical-cancer-updated-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-muc5ac-as-a-dynamic-biomarker-for-tumor-response-prognosis-and-risk-stratification-in-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linking-comfort-levels-and-knowledge-gaps-in-hematologyoncology-ho-fellowship-education-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysing-the-impact-of-size-of-ngs-panel-in-defining-first-line-therapeutic-strategies-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-nimotuzumab-addition-to-neoadjuvant-chemotherapy-in-pancreatic-carcinoma-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-burden-of-uterine-cancer-in-the-eu-from-1990-2021-global-and-national-disparities-age 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-comparative-efficacies-of-camrelizumab-as-a-single-or-combination-therapy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-spectrum-of-cell-proliferation-genes-as-early-predictive-markers-for-aggressive-disease-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-in-recurrent-ovarian-cancer-an-updated-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-clinical-trial-interpretability-and-efficiency-a-bayesian-re-analysis-of-individual-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-implementation-of-virtual-oncology-and-hematology-services-in-a-rural-health-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-plasma-metabolomic-profile-to-predict-breast-cancer-survival-risk-stratification-based-on-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solid-tumor-specific-patterns-of-immune-related-adverse-events-due-to-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-role-of-ccnd1-in-neoadjuvant-therapy-efficacy-in-esophageal-squamous-cell-carcinoma-and-it 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-angiotensin-converting-enzyme-inhibitors-aceis-or-angiotensin-ii-receptor-blockers-arbs-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endoscopic-submucosal-dissection-with-adjuvant-chemotherapy-for-early-gastric-cancer-unnecessary-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-paclitaxel-and-nedaplatin-as-neoadjuvant-therapy-for-locally-advanced-eso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unpacking-the-relationship-between-cancer-survival-and-political-environment-in-the-united-states-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-clinical-benefits-of-genomic-profiling-for-advanced-solid-tumors-in-portugal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-the-nalirifox-regimen-in-perioperative-treatment-of-borderline-resectable-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-patterns-of-care-referral-to-palliative-care-for-patients-with-metastatic-gynecologic-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-care-on-mortality-length-of-stay-and-hospital-charges-in-common-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utilization-of-patient-derived-organoids-as-a-platform-for-predicting-the-efficacy-of-anti-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ampullary-adenocarcinoma-what-is-the-best-approach-insights-from-a-large-retrospective-series 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-efficacy-of-endonuclease-inhibition-in-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-in-hispaniclatino-hl-with-metastatic-renal-cell-carcinoma-mrcc-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-oral-contraceptive-use-and-pancreatic-cancer-risk-an-updated-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypertension-and-vegf-a-level-correlation-in-cancer-patients-starting-vegf-inhibitors-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-immune-inflammation-index-as-a-survival-predictor-in-advanced-urothelial-carcinoma-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-stage-ii-and-iii-medullary-renal-cancer-patients-treated-with-perioperative-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-and-the-risk-of-chemotherapy-induced-peripheral-neuropathy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-survival-outcomes-in-secondary-acute-myeloid-leukemia-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-patients-with-acute-lymphoblastic-leukemia-a-focus-on-young-adult-and-adole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-stampede2-trial-a-site-survey-of-current-patterns-of-care-access-to-imaging-and-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-as-a-predictor-of-in-hospital-outcomes-in-esrd-patients-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-macrophage-checkpoint-clever-1-inhibition-with-bexmarilimab-plus-azacitidine-in-myelodys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-advanced-practice-providers-in-a-clinical-research-program-to-provide-trial-prescreening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-access-to-novel-high-cost-therapies-across-canada-a-survey-of-pediatric-oncology-prov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-precision-medicine-in-the-management-of-metastatic-prostate-cancer-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-10-day-astx727-decitabinecedazuridine-in-combination-with-venetoclax-for-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-concomitant-egfr-and-smarca4-mutations-in-an-east-asian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-using-ngs-in-lung-cancer-patients-revolutionizing-targeted-therapy-and-personal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-local-estrogen-therapy-among-breast-cancer-patients-in-seer-mhos-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-baseline-characteristics-and-diagnostic-path-of-polish-patients-with-alk-positive-nsclc-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-her2-expression-in-prostate-cancer-among-mexican-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-hospitalization-outcomes-among-adult-patients-with-prostate-cancer-using-the-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disco-app-a-patient-intervention-to-reduce-the-financial-burden-of-cancer-in-a-diverse-patient-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-deep-learning-model-artificial-intelligence-and-radiologists-in-breast-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-large-language-model-to-predict-loss-to-follow-up-for-oncology-patients-discharged-to-skill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-advances-in-feature-selection-methods-for-breast-cancer-recurrence-prediction-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cox-models-vs-machine-learning-for-survival-prediction-do-traditional-approaches-still-hold-their 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practice-patterns-related-to-ovarian-function-suppression-in-the-swog-s2010-clinical-trial-of-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-quality-of-life-inclusion-in-phase-iii-clinical-trials-for-advanced-gastrointestinal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-navigation-bronchoscopy-vs-shape-sensing-robotic-assisted-bronchoscopy-in-terms-of-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-cabozantinib-in-patients-with-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-barriers-for-patients-with-stage-iv-non-small-cell-lung-cancer-with-brain-metastases-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mri-biomarkers-on-survival-in-tnbc-patients-a-retrospective-multi-center-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-imeti-genomic-alterations-ga-identified-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-entrectinib-in-children-with-extracranial-solid-or-primary-central-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risk-factor-control-and-risk-of-future-cardiovascular-events-in-survivors-of-childhoo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-intratumoural-bacteria-in-resistance-to-lag-3-targeting-therapeutics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-features-of-non-small-cell-lung-cancer-patients-with-ibrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-patients-with-multiple-myeloma-treated-with-t-cell-engagers-compared-to-those 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-study-to-assess-the-oncolytic-virus-vcn-01-safety-and-efficacy-in-refracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-prognostic-biomarker-for-long-term-survival-in-de-novo-oligometastatic-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-demographic-and-socioeconomic-factors-in-eccrine-adenocarcinoma-a-national-cancer-databas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analyses-of-first-line-immune-checkpoint-inhibitors-in-unresectable-merkel-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-maintenance-therapy-strategy-for-metastatic-nasopharyngeal-carcinoma-insights-from-a-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-early-ebv-dna-clearance-to-select-optimal-induction-chemotherapy-cycles-for-locoregional-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-adverse-events-in-multiple-myeloma-patients-a-comparative-study-analysis-of-daratumu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-biomarker-directed-multi-center-phase-iiiii-study-of-ctdna-molecular-response-adaptive-immuno-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-infection-risk-factors-and-related-complications-in-newly-diagnosed-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hla-matching-on-clinical-outcomes-in-a-phase-2-trial-of-bria-imt-plus-anti-pd1-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-neurological-disorders-and-negative-outcomes-in-head-and-neck-cancer-patients-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-clinical-outcomes-and-dna-co-alterations-of-erbb2-amplified-colorectal-cancer 2026-08-24 monthly 0.7